The iconic rise of Viagra has long been a example of pharmaceutical success, but its future within the broader sector now presents questions about potential yields . Generic versions are undercutting exclusivity , leading to anxieties that supporting companies closely tied to Viagra's previous standing could be a problematic decision , especially g